Valeant Pharmaceuticals To Participate In September Healthcare Conferences

LAVAL, Quebec, Aug. 30, 2016 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences in September:

  • Wells Fargo Healthcare Conference on Wednesday, September 7, at 3:30 p.m. ET at the Westin Waterfront Hotel in Boston; and,
  • Morgan Stanley Global Healthcare Conference on Tuesday, September 13, at 9:10 a.m. ET at the Grand Hyatt Hotel in New York City.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL:

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Contact Information:

Elif McDonald
877-281-6642 (toll free)

Renée Soto
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.

Logo - 

SOURCE Valeant Pharmaceuticals International, Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890